FaceTite IgniteRF is an advanced technology for the treatment of small body areas. It is indicated for dermatological and general surgical procedures where contraction of soft tissue or hemostasis is needed. It leverages RFAL power, and is designed with a non-aspirating cannula with a plastic tip. FaceTite IgniteRF enables physicians to work in the subdermal plane safely and effectively
Workstation: IGNITE RF
BODYTITE IGNITERF
BodyTite IgniteRF is a clinically proven minimally invasive technology powered by RadioFrequency Assisted Lipo-coagulation (RFAL) for the treatment of larger body areas. It is indicated for dermatological and general surgical procedures where contraction of soft tissue or hemostasis is needed. BodyTite IgniteRF, in a single treatment, delivers unprecedented contraction results previously only achieved through more extensive surgical procedures.
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
IRVINE, Calif., July 17, 2024 /PRNewswire/ — InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, is pleased to announce an additional FDA 510(k) clearance for the Morpheus8 technology. Morpheus8 is the first and only fractional radiofrequency (FRF) microneedling technology cleared for contraction of soft tissue.
The U.S. Food and Drug Administration (FDA) has cleared the use of the Morpheus8 Applicators for the delivery of fractional radiofrequency use in dermatologic skin procedures where coagulation/contraction of soft tissue or hemostasis is needed. This FDA action expands Morpheus8’s existing FDA clearance, emphasizing the versatility of the technology for physicians and patients.
Coinciding with this clearance is the launch of the new IgniteRF and OptimasMAX platforms, which include the Morpheus8 family of handpieces. The modular portfolio of tips, including Prime 12 pin, Morpheus8 24 pin, Resurfacing 24 pin, and Morpheus8 40 pin, makes this technology a versatile solution delivering exceptional patient results. The IgniteRF and OptimasMAX platforms support 14 technologies, including minimally invasive radiofrequency assisted soft tissue coagulation and contraction, non-invasive thermal radiofrequency, intense pulsed light skin treatments, and multi-wavelength hair reduction.
“InMode is dedicated to investing in R&D so we can provide medical professionals with continued advancements they need to deliver the highest quality of care and best-in-class results,” said Moshe Mizrahy, CEO of InMode. “The new indication for soft tissue contraction enhances the product’s intended use, helping Morpheus8 practitioners expand their patient base.”
Since inception, Morpheus8 has gained widespread global brand awareness, with more than 2.5 million procedures performed worldwide, and an average of 8.2 treatments performed every minute. The Morpheus8 brand has become so popular that consumers and celebrities request it by name. It is a trusted procedure known for delivering both natural and striking results.
Find out more – Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
Dr. Jason Bloom
FaceTite is an advanced minimally invasive technology for the treatment of small areas through soft tissue coagulation. It delivers unparalleled clinical results in a single treatment.
MORPHEUS8 burstdeep
Morpheus8 Burst Deep is a fractional radiofrequency (FRF) technology intended for dermatological applications that require contraction/coagulation of soft tissue or hemostasis. With the ability to deliver both subdermal multi-level contraction and dermal contraction, Morpheus8 Burst Deep provides the deepest levels of targeted RF energy deposition available. Equipped with proprietary Burst and Scale technologies, Morpheus8 Burst Deep’s large 40-pin surface tip automatically deploys bipolar RF energy, in millisecond intervals, to multi-level treatment depths and energy levels in a single pulse.
MORPHEUS8 Burst
Morpheus8 Burst is a fractional radiofrequency (FRF) technology intended for dermatological applications that require contraction/coagulation of soft tissue or hemostasis. Equipped with proprietary Scale and Burst functionalities, these innovative technologies automatically deploy bipolar RF to multi-level treatment depths and programmable energy levels in millisecond intervals with a single pulse. This range of functionality makes Morpheus8 Burst a versatile tool to safely and efficaciously meet patient demand for dermal contraction and subdermal adipose treatments.
ACCUTITE IGNITERF
AccuTite IgniteRF is the smallest minimally invasive RF device in the RFAL family of products. It is indicated for dermatological and general surgical procedures where contraction of soft tissue or hemostasis is needed. AccuTite IgniteRF is an advanced technology for the precise treatment of delicate areas. Built-in safeguards include real time measurements of skin temperature, impedance monitoring, power cut-off, and audible feedback.
QUANTUMRF 10
QuantumRF 10 is an innovative minimally invasive technology indicated for soft tissue contraction. It leverages clinically proven fractionated radiofrequency to maximal depths in smaller zones. The small, easy-to-use handpiece delivers precision pulsed bipolar RF energy to the subdermal plexus, resulting in shorter downtimes and safer procedures.
QUANTUMRF 25
QuantumRF 25 is an advanced minimally invasive technology that is cleared for soft tissue contraction by deploying clinically proven fractionated radiofrequency to maximal depths. The Teflon coated, lightweight handpiece, delivers deep, pulsed bipolar RF to larger areas without damaging the dermis, making procedures remarkably fast and more efficient than other devices.
FACETITEturbo
FaceTite Turbo is a minimally invasive handpiece, designed with a rigid cannula, providing greater control, precision, and safety in small, delicate tissue zones.
